🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
TCR-T cell therapy experienced a breakthrough for treating tumors in recent...
Status
Unknown
Location
Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University
Start Date
2017-03-21
Trial ID
NCT03029273
Treatments Being Tested
The MONET BRIDGE study is designed to assess the use of cangrelor as a plat...
Status
Unknown
Location
Multiple Locations
Start Date
2019-06-01
Trial ID
NCT03862651
Treatments Being Tested
This is an investigator-initiated clinical trial evaluating the safety, tol...
Status
Active Not Recruiting
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2024-12-30
Trial ID
NCT07461181
Treatments Being Tested
Although new techniques like extracorporeal blood purification have lately ...
Status
Unknown
Location
University Hospital Center Zagreb
Start Date
2022-10-25
Trial ID
NCT05608096
Treatments Being Tested
A Phase 2 Randomized, Double-blind, Placebo-Controlled Study of the Safety ...
Status
Recruiting
Location
EncompaSSc site in Phoenix, AZ
Start Date
2026-04-16
Trial ID
NCT07287670
Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2023-03-30
Trial ID
NCT05467670
Treatments Being Tested
The primary objective of this trial is to measure changes in physiologic si...
Status
Recruiting
Location
Hazelden Betty Ford Foundation
Start Date
2025-02-19
Trial ID
NCT06487533
Treatments Being Tested
The objective of this study is to examine the impact of a free health insur...
Status
Active Not Recruiting
Location
Bali LGA
Start Date
2023-10-01
Trial ID
NCT07313631
Treatments Being Tested
The goal of this clinical trial is to study the combination of nivolumab an...
Status
Active Not Recruiting
Location
Karmanos Cancer Institute
Start Date
2023-05-03
Trial ID
NCT05723055
Treatments Being Tested
This is a 52 week, single center, randomized, double-blind, placebo-control...
Status
Recruiting
Location
Hospital for Special Surgery
Start Date
2019-07-29
Trial ID
NCT03844061
Treatments Being Tested